EligibleTrials

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

Recruiting · NCT05213676 · Interventional (participants receive a specific treatment) · Lead sponsor: The University of Texas Health Science Center, Houston

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

De-implementation of Inhaled Nitric Oxide (iNO) useInhaled Nitric Oxide (iNO) use

What this trial is about

The purpose of this study is to determine if de-implementation of inhaled nitric oxide (iNO) in the post-natal resuscitation/stabilization phase affects the composite outcome of extracorporeal life support (ECLS) use and/or mortality, as well as ECLS use, mortality, and/or oxygenation in congenital diaphragmatic hernia (CDH) newborns and to establish the cost-effectiveness of de-implementing iNO as a therapy in the postnatal resuscitation/stabilization phase of CDH management, which will be assessed as the incremental health system costs (savings) per prevented ECLS use and/or death.

Who can take part

Age range
0 Months to 1 Month
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

19 locations listed across 15 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.